These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38367664)

  • 21. Expression, purification and characterisation of soluble GlfT and the identification of a novel galactofuranosyltransferase Rv3782 involved in priming GlfT-mediated galactan polymerisation in Mycobacterium tuberculosis.
    Alderwick LJ; Dover LG; Veerapen N; Gurcha SS; Kremer L; Roper DL; Pathak AK; Reynolds RC; Besra GS
    Protein Expr Purif; 2008 Apr; 58(2):332-41. PubMed ID: 18248822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
    Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
    Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Evaluation of Bicyclo[3.1.0]hexane-Based UDP-Galf Analogues as Inhibitors of the Mycobacterial Galactofuranosyltransferase GlfT2.
    Lowary TL; Li J
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring processivity and length control of a carbohydrate polymerase.
    Levengood MR; Splain RA; Kiessling LL
    J Am Chem Soc; 2011 Aug; 133(32):12758-66. PubMed ID: 21739979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis of Galactan in
    Konyariková Z; Savková K; Kozmon S; Mikušová K
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31935842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability.
    Mills JA; Motichka K; Jucker M; Wu HP; Uhlik BC; Stern RJ; Scherman MS; Vissa VD; Pan F; Kundu M; Ma YF; McNeil M
    J Biol Chem; 2004 Oct; 279(42):43540-6. PubMed ID: 15294902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.
    Brennan PJ
    Tuberculosis (Edinb); 2003; 83(1-3):91-7. PubMed ID: 12758196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.
    Deng L; Mikusová K; Robuck KG; Scherman M; Brennan PJ; McNeil MR
    Antimicrob Agents Chemother; 1995 Mar; 39(3):694-701. PubMed ID: 7793875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster.
    Dianišková P; Korduláková J; Skovierová H; Kaur D; Jackson M; Brennan PJ; Mikušová K
    Gen Physiol Biophys; 2011 Sep; 30(3):239-50. PubMed ID: 21952433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae.
    Guan S; Clarke AJ; Whitfield C
    J Bacteriol; 2001 Jun; 183(11):3318-27. PubMed ID: 11344139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arabinogalactan enhances
    Li YY; Liu HM; Wang D; Lu Y; Ding C; Zhou LS; Wu XY; Zhou ZW; Xu SQ; Lin C; Qin LH; Li Y; Liu J; Liu HP; Zhang L
    Front Immunol; 2022; 13():879775. PubMed ID: 36090984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.
    Rombouts Y; Brust B; Ojha AK; Maes E; Coddeville B; Elass-Rochard E; Kremer L; Guerardel Y
    J Biol Chem; 2012 Mar; 287(14):11060-9. PubMed ID: 22315220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Synthetic Glycolipids to Probe the Number and Position of Arabinan Chains on Mycobacterial Arabinogalactan.
    Angala SK; Joe M; McNeil MR; Liav A; Lowary TL; Jackson M
    ACS Chem Biol; 2021 Jan; 16(1):20-26. PubMed ID: 33382235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis.
    Alderwick LJ; Seidel M; Sahm H; Besra GS; Eggeling L
    J Biol Chem; 2006 Jun; 281(23):15653-61. PubMed ID: 16595677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galactosyltransferases from Arabidopsis thaliana in the biosynthesis of type II arabinogalactan: molecular interaction enhances enzyme activity.
    Dilokpimol A; Poulsen CP; Vereb G; Kaneko S; Schulz A; Geshi N
    BMC Plant Biol; 2014 Apr; 14():90. PubMed ID: 24693939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacterium smegmatis.
    Jiang T; He L; Zhan Y; Zang S; Ma Y; Zhao X; Zhang C; Xin Y
    Microb Pathog; 2011 Sep; 51(3):156-60. PubMed ID: 21575707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.
    Wolucka BA; McNeil MR; de Hoffmann E; Chojnacki T; Brennan PJ
    J Biol Chem; 1994 Sep; 269(37):23328-35. PubMed ID: 8083238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.
    Mikusová K; Slayden RA; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2484-9. PubMed ID: 8585730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1.
    Clarke BR; Bronner D; Keenleyside WJ; Severn WB; Richards JC; Whitfield C
    J Bacteriol; 1995 Oct; 177(19):5411-8. PubMed ID: 7559323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies.
    Ortiz CLD; Completo GC; Nacario RC; Nellas RB
    Sci Rep; 2019 Nov; 9(1):17096. PubMed ID: 31745103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.